Strides Pharma gains on transfer of Bengaluru facility to Syngene Hot Stocks admin December 4, 2023 0 87 1 minute read Stelis and Syngene have executed the final agreements to transfer its Unit 3 multi-modal facility in Bengaluru to Syngene with gross consideration adjusted from Rs 702 crore to Rs 617 crore.